Pathway Financial Advisers’s CVS Health CVS Stock Holding History

Pathway Financial Advisers’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,237	Closed	-$706K	–	378
2025 Q2	$706K	Buy	10,237 +222	+2%	+$14.6K	0.23%	109
2025 Q1	$679K	Sell	10,015 -13,541	-57%	-$810K	0.23%	108
2024 Q4	$1.06M	Sell	23,556 -1,706,787	-99%	-$95.8M	0.35%	89
2024 Q3	$27.5K	Buy	1,730,343 +1,701,331	+5,864%	+$99.3M	0.01%	225
2024 Q2	$1.71M	Sell	29,012 -1,345	-4%	-$84.1K	0.61%	58
2024 Q1	$2.42M	Buy	30,357 +183	+0.6%	+$14K	0.87%	35
2023 Q4	$2.38M	Sell	30,174 -1,568	-5%	-$112K	0.91%	34
2023 Q3	$2.22M	Buy	+31,742	New	+$2.25M	0.92%	36
2023 Q1	$1.89M	Buy	25,483 +1,482	+6%	+$124K	0.76%	48
2022 Q4	$2.24M	Buy	+24,001	New	+$2.32M	0.91%	35

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pathway Financial Advisers's CVS Position: Q3 2025 in Review

Pathway Financial Advisers sold out of CVS Health (CVS) in Q3 2025, closing a stake of 10,237 shares — an estimated $706K sold.

Pathway Financial Advisers first reported a position in CVS in Q4 2022 and held it in 10 quarters. The position peaked at $2.42M in Q1 2024. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

Pathway Financial Advisers reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
Pathway Financial Advisers sold 10,237 CVS Health shares in Q3 2025, an estimated $706K.
Pathway Financial Advisers first reported a position in CVS Health in Q4 2022 and held it in 10 quarters.
Pathway Financial Advisers's CVS Health position peaked at $2.42M in Q1 2024.
1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Pathway Financial Advisers's 13F filing for Q3 2025, filed 13 Nov 2025.